Early Fluid Resolution Predicts Faricimab Durability - Quiz - MDSpire

Early Fluid Resolution Predicts Faricimab Durability

Post hoc analysis suggests rapid retinal fluid resolution may help identify patients with nAMD who can maintain longer faricimab dosing intervals.

  • By

  • Conexiant News Staff

  • March 11, 2026

  • 4 min

Share

Original Source(s)

Early Fluid Resolution Predicts Faricimab Durability

  • by Conexiant News Staff

  • March 11, 2026

Related Content

Diagnosing and Managing Polypoidal Choroidal Vasculopathy

Polypoidal choroidal vasculopathy (PCV) is a distinct choroidal vascular disorder often considered a variant of age-related macular degeneration (AMD), although features such as drusen, pigmentary changes, and geographic atrophy are uncommon.

Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy

Lutein Supplementation May Improve Outcomes in Early AMD

Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease